TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/15/24 16:25 | 7/11/24 | GMED | Globus Medical Inc | DE | Health | MdEq | Surgical & Medical Instrument | Norwalk Leslie V | PA | D | S | -70 | 70.00 | 0 | -1 | -6 | 16 | D | |||||||||||||||
5/21/24 17:06 | 5/17/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Norwalk Leslie V | CA | D | S.d | -157 | 141.82 | 0 | -1 | -53 | 1 | D | |||||||||||||||
3/19/24 19:40 | 3/15/24 | GMED | Globus Medical Inc | DE | Health | MdEq | Surgical & Medical Instrument | Norwalk Leslie V | PA | D | S | -551 | 51.99 | 0 | -11 | -38 | 17 | D | |||||||||||||||
2/29/24 18:50 | 2/27/24 | NBIX | Neurocrine Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Norwalk Leslie V | CA | D | S.d | -1,085 | 135.67 | 0 | -8 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |